Search Results

There are 7244777 results for: content related to: A meta-analysis comparing trials of antimuscarinic medications funded by industry or not

  1. Which anticholinergic drug for overactive bladder symptoms in adults

    Intervention Review

    The Cochrane Library

    Priya Madhuvrata, June D Cody, Gaye Ellis, G Peter Herbison and E. Jean C Hay-Smith

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005429.pub2

  2. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 567–585, C. C. Sexton, S. M. Notte, C. Maroulis, R. R. Dmochowski, L. Cardozo, D. Subramanian and K. S. Coyne

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1742-1241.2010.02626.x

  3. You have free access to this content
    Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial

    BJU International

    Volume 92, Issue 7, November 2003, Pages: 741–747, Y. Homma, J.S. Paick, J.G. Lee, K. Kawabe and the Japanese and Korean Tolterodine Study Group

    Version of Record online : 27 OCT 2003, DOI: 10.1046/j.1464-410X.2003.04468.x

  4. Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 961–968, Roger Dmochowski, Andrew Chen, Gayatri Sathyan, Scott MacDiarmid, Shalini Gidwani and Suneel Gupta

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278055

  5. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

    International Journal of Clinical Practice

    Volume 65, Issue 4, April 2011, Pages: 487–507, S. A. Kaplan, C. G. Roehrborn, P. Abrams, C. R. Chapple, T. Bavendam and Z. Guan

    Version of Record online : 7 JAN 2011, DOI: 10.1111/j.1742-1241.2010.02611.x

  6. You have free access to this content
    Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

    British Journal of Urology

    Volume 81, Issue 6, June 1998, Pages: 801–810, Abrams, Freeman, AnderstrÖM and Mattiasson

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1464-410x.1998.00717.x

  7. You have free access to this content
    The use of tolterodine in children after oxybutynin failure

    BJU International

    Volume 91, Issue 4, March 2003, Pages: 398–401, S. Bolduc, J. Upadhyay, J. Payton, D.J. Bägli, G.A. McLorie, A.E. Khoury and W. Farhat

    Version of Record online : 30 JUL 2009, DOI: 10.1046/j.1464-410X.2003.04085.x

  8. You have free access to this content
    Muscarinic receptor antagonists for overactive bladder

    BJU International

    Volume 100, Issue 5, November 2007, Pages: 987–1006, Paul Abrams and Karl-Erik Andersson

    Version of Record online : 3 OCT 2007, DOI: 10.1111/j.1464-410X.2007.07205.x

  9. You have free access to this content
    Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability

    International Journal of Urology

    Volume 13, Issue 2, February 2006, Pages: 105–108, NIZAMETTIN KILIC, EMIN BALKAN, SEMRA AKGOZ, NURI SEN and HASAN DOGRUYOL

    Version of Record online : 6 MAR 2006, DOI: 10.1111/j.1442-2042.2006.01240.x

  10. You have free access to this content
    Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder

    International Journal of Urology

    Volume 9, Issue 5, May 2002, Pages: 247–252, Jeong Gu Lee, Jae Yup Hong, Myung-Soo Choo, Hun Young Kwon, Do Young Chung, Kyu Sung Lee, Ji Youl Lee and Tack Lee

    Version of Record online : 24 JUN 2002, DOI: 10.1046/j.1442-2042.2002.00460.x

  11. You have free access to this content
    Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial

    British Journal of Clinical Pharmacology

    Volume 59, Issue 5, May 2005, Pages: 588–592, R. Altan-Yaycioglu, O. Yaycioglu, Y. Aydin Akova, S. Guvel and H. Ozkardes

    Version of Record online : 2 MAR 2005, DOI: 10.1111/j.1365-2125.2005.02356.x

  12. You have free access to this content
    Tolterodine and its Active 5-Hydroxymethyl Metabolite: Pure Muscarinic Receptor Antagonists

    Pharmacology & Toxicology

    Volume 90, Issue 5, May 2002, Pages: 260–267, Lisbeth Nilvebrant

    Version of Record online : 18 JUN 2002, DOI: 10.1034/j.1600-0773.2002.900506.x

  13. Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years

    Journal of Obstetrics and Gynaecology Research

    Volume 41, Issue 1, January 2015, Pages: 120–126, Mina Jafarabadi, Ladan Jafarabadi, Mamak Shariat, Gelareh Rabie Salehi, Fedyeh Haghollahi and Batool Hossein Rashidi

    Version of Record online : 5 NOV 2014, DOI: 10.1111/jog.12483

  14. You have free access to this content
    The overactive bladder in children: a potential future indication for tolterodine

    BJU International

    Volume 87, Issue 6, April 2001, Pages: 569–574, K. Hjälmås, A-L. Hellström, K. Mogren, G. Läckgren and A. Stenberg

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1464-410X.2001.00084.x

  15. Urge Urinary Incontinence

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt089

  16. You have free access to this content
    MUSCARINIC RECEPTOR ANTAGONISTS IN THE TREATMENT OF OVERACTIVE BLADDER

    BJU International

    Volume 85, Issue S3, May 2000, Pages: 33–46, CHRISTOPHER R. CHAPPLE

    Version of Record online : 18 MAR 2014, DOI: 10.1111/j.1464-410X.2000.tb16941.x

  17. You have free access to this content
    The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service

    BJU International

    Volume 106, Issue 4, August 2010, Pages: 506–514, Linda Cardozo, Andrew Thorpe, Juliet Warner and Manpreet Sidhu

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1464-410X.2009.09160.x

  18. You have free access to this content
    AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1119–1127, S Sinha, S Gupta, S Malhotra, NS Krishna, AV Meru, V Babu, V Bansal, M Garg, N Kumar, A Chugh and A Ray

    Version of Record online : 19 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00752.x

  19. You have free access to this content
    Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1767–1774, Adrian Wagg, Gerhard Compion, Amanda Fahey and Emad Siddiqui

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11023.x

  20. You have free access to this content
    Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial

    BJU International

    Volume 107, Issue 9, May 2011, Pages: 1432–1440, Steven A. Kaplan, Tim Schneider, Jenelle E. Foote, Zhonghong Guan, Martin Carlsson and Jason Gong

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09640.x